But well get to the point where there are a lot of different options on the market, and then its going to be up to which one has the most catchy drug pitch, advertisement, or name. The success of GLP-1 drugs may also influence future drug development trends
If you do try it, start with a very small amount (half a teaspoon) in a large glass of water and monitor how your body responds
Here's What the Evidence and the FDA Label Actually Say These are two of the most searched questions in this category right now - and they deserve direct answers, not hedged non-answers
Due to how common obesity is in the United States as well as the cost implications, if and when GLP-1 drugs are covered is a primary area of focus
2024 NEJM) showing 24% kidney and CV death reduction if you have CKD
Clinical trials show semaglutide produces an average body weight reduction of 15% or more, and tirzepatide produces reductions exceeding 20% in some populations